Latest news with #Internal
Yahoo
a day ago
- Business
- Yahoo
Is National Bank of Canada Stock a Buy Now?
Written by Brian Paradza, CFA at The Motley Fool Canada National Bank of Canada (TSX:NA) recently delivered a quarter that turned heads. With its recent blockbuster acquisition of Canadian Western Bank (CWB) finally reflected in the numbers, investors are rightly asking: Is this Canadian bank stock a smart buy for a long-term oriented portfolio today, especially looking out over the next three to five years? Let's dive into the story unfolding at National Bank. The $5 billion purchase of CWB, announced back in June 2024 and closed in February this year, wasn't just another deal. It was a strategic masterstroke, significantly boosting National Bank's presence in Western Canada — a region where it historically had less muscle. The acquisition was a significant step forward in the acceleration of the bank's domestic strategy. The early results are promising. National Bank of Canada is firing on all cylinders. Adjusted earnings per share (EPS) jumped 12% year over year to $2.85 for the quarter ending April 2025. Its market-leading return on equity (ROE) of 15.6% is the envy of its peers. Income before provisions for credit losses and taxes surged 34% during the past quarter! This stellar performance wasn't just about volatile trading markets having a good run (though that helped); it reflected solid organic growth across personal, commercial, and wealth management segments. Now, add CWB into the mix. Personal and Commercial Banking revenue soared 25% year over year (4% organically excluding CWB). Wealth Management revenue climbed 16%. The initial integration, according to management, is advancing 'ahead of schedule,' particularly on cost and funding synergies. The bank has already banked $27 million in synergies this past quarter alone — a whopping 43% of its three-year target already captured annually! This early traction suggests the promised synergistic benefits of the deal are real and potentially achievable. Buying CWB did affect capitalization. The bank's common equity tier-one (CET1) ratio, a key measure of a bank's financial strength, has dipped slightly to 13.4% from 13.7%. However, this capitalization level remains robust, well above regulatory requirements, and high enough to keep the dividend growth spree rolling. Management recently highlighted future potential capital relief as the bank migrates CWB portfolios onto its more advanced risk models (Advanced Internal Ratings-Based approach, or AIRB), expected mainly in 2026. While share buybacks are on hold for now, with a focus on growth and integration, a clearer capital return plan could be out by year-end. It's not all smooth sailing for the National Bank of Canada. The broader economic picture holds uncertainty. Global trade tensions, high long-term interest rates, and potential impacts from tariffs are recurring themes to watch. While the bank emphasizes its 'cautious approach' and 'prudent provisioning,' its credit metrics, while manageable, did see some expected pressure from absorbing CWB last quarter. The big question mark for some investors could be the bank's stellar trading revenue — can it last? Volatile market environments, like the one seen early this year, are ideal trading environments, but performance should normalize going forward. Income investors, take note. National Bank boasts a solid 3.5% dividend yield. More impressively, it recently announced another dividend hike in May that marked its 16th consecutive annual increase. The bank stock's dividend payout ratio sits at a comfortable 42.2%, down from 43.2% a year ago, signalling sustainability and room for future growth. This consistent return of capital is a major plus for long-term holders. The bank stock's dividend amplified its total returns from 123% to more than 170% during the past five years. NA data by YCharts So, is National Bank of Canada stock a buy now? The bank stock's investment case looks compelling for investors with a three- to five-year horizon. Shares appear fairly valued with a price-earnings-to-growth (PEG) ratio of 0.9. The CWB acquisition brought about a strategic transformation that gives the bank a national scale and a strong Western platform in Canada. Early integration efforts are exceeding expectations, and recent organic growth exhibits the bank's underlying strength and potential to continue growing earnings and investors' capital. A consistently growing dividend could amplify shareholders' rewards. The post Is National Bank of Canada Stock a Buy Now? appeared first on The Motley Fool Canada. More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Fool contributor Brian Paradza has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. 2025 Sign in to access your portfolio
New Indian Express
29-04-2025
- Politics
- New Indian Express
Punjab DGP Gaurav Yadav sets May 31 deadline to eradicate drug menace from state
CHANDIGARH: Director General of Police, Punjab, Gaurav Yadav has set May 31 deadline to eradicate the drug menace from the state. He has issued a stern ultimatum to the police commissioners and district police chiefs to bring down the availability of drugs in the streets. He also said that all officers will be accountable if they fail to do so. An hour-long high-level meeting was chaired with all the Range Inspector Generals of Police, Deputy Inspector Generals, Commissioners of Police, Senior Superintendents of Police and accompanied by Special DGP Internal Security RN Dhoke, ADGP Anti Narcotics Task Force (ANTF) Nilabh Kishore and ADGP Law and Order Naresh Arora, to make the ongoing action plan to wipe out drugs from the state foolproof in toto. "We have taken several important decisions during the meeting, including fixing the accountability of the officers. Every officer, including CPs, SSPs, DSPs and SHOs will be held responsible and accountable in their own respective areas for failing to wipe out drugs from the streets," said Yadav. He also said the performance of all the officers will be assessed with the help of professional parameters, intelligence and feedback from the public after May 31. "After the survey, officers who did good work will be rewarded, while punishments will be given to the officers found deficient,'' he said. Yadav, however, clarified that the focus of the police is not a figure based targets, but to completely break the supply chains to make drugs unavailable across the state. CPs and SSPs have already been directed to trace the linkages of the cases being registered under the NDPS act and also to take the cases to logical conclusion by exposing complete networks, he added. Pertinently, the meeting took place in two parts— with the review of district wise performance including number of FIRs registered, achievements and gaps were discussed with the respective Range IGPs, DIGs, CPs and SSPs in first part, while, in second part, field officers were asked to present their plan to eradicate drugs from their respective districts by May 31. Yadav said that, during the meeting, officers have also discussed various mechanisms and techniques to go after big fish and how to track them by leveraging the use of technology as a force multiplier. 'With criminals using cut-out techniques and virtual numbers to evade arrest, we have devised a foolproof strategy to catch such criminals using technical and human intelligence,' he added. He said that Punjab Police has been giving special focus on the 755 identified drug hotspots with repeated targeted and effective CASO operations to ensure denial of access to drugs in these vulnerable areas.
Associated Press
04-04-2025
- Health
- Associated Press
Dr. M. Tyrrell Burrus, Leading Orthopedic Surgeon in Austin, Introduces Advanced Surgical Techniques for Shoulder, Knee, and Ankle Care
Austin, TX – Dr. M. Tyrrell Burrus, a trusted name in orthopedic surgery in Austin, is proud to announce the integration of cutting-edge technologies and advanced surgical techniques into his practice. As a renowned shoulder surgeon in Austin, Dr. Burrus is committed to providing his patients with the latest, most effective treatments available to ensure faster recovery and improved outcomes. With the addition of innovative shoulder and knee procedures, Dr. Burrus continues to lead the way in orthopedic care. Shoulder Replacements with Advanced Templating Technology In an effort to offer the best possible outcomes for patients requiring shoulder replacement surgery, Dr. Burrus now utilizes the Arthrex Virtual Implant Positioning™ (VIP) System for precise and accurate shoulder surgery. This advanced templating software allows for optimal placement of the shoulder implant, improving alignment, reducing surgical time, and enhancing recovery for patients. As a trusted shoulder doctor Austin, Dr. Burrus is dedicated to utilizing the most advanced tools available to improve patient satisfaction and long-term results. ACL Reconstruction with Quadriceps Tendon Autograft Dr. Burrus is now offering ACL reconstruction surgery using quadriceps tendon autograft, a minimally invasive technique that is transforming ACL repair. The QuadPro™ tendon harvester, provided by Arthrex, is designed to harvest a quadriceps or patellar tendon graft with precision and minimal disruption to surrounding tissue. This technique enhances recovery time and reduces the risk of complications, making it an ideal choice for patients looking for a safer, more effective ACL reconstruction option. As a leading knee surgeon Austin, Dr. Burrus employs this innovative technology to address knee injuries with the utmost care and precision. ACL Surgery with Internal Brace Backup Fixation For those undergoing ACL reconstruction, Dr. Burrus offers the Arthrex ACL Backup Fixation System, which provides enhanced tibial fixation to ensure the strength and stability of the graft during healing. This system includes a SwiveLock® implant and a spade-tipped drill, allowing for strong, reproducible fixation that is critical for successful outcomes. The InternalBrace™ ligament augmentation technology further strengthens the repaired ACL, making it ideal for patients with high activity levels. Dr. Burrus, a leading knee specialist Austin, is proud to offer this advanced solution to patients seeking comprehensive ACL repair options. MPFL Reconstruction for Patellar Instability For patients experiencing patellar instability, Dr. Burrus now offers the Arthrex MPFL Reconstruction procedure, utilizing an anatomic double-bundle technique to replicate the natural shape of the medial patellofemoral ligament (MPFL). This technique provides stability in both flexion and extension, helping to prevent rotational instability throughout the range of motion. As a trusted knee doctor Austin, Dr. Burrus provides effective solutions for patients struggling with patellar instability, allowing them to return to normal activity levels with improved confidence and mobility. Comprehensive Ankle Care In addition to his expertise in shoulder and knee care, Dr. Burrus also offers comprehensive ankle surgery services in Austin. As a highly experienced ankle surgeon Austin, he provides personalized treatment plans for patients dealing with a variety of ankle injuries and conditions. From fractures to chronic instability, Dr. Burrus offers advanced surgical options to help patients regain mobility and improve their quality of life. About Dr. M. Tyrrell Burrus, MD Dr. M. Tyrrell Burrus is an experienced orthopedic surgeon specializing in shoulder, knee, and ankle surgery in Austin, TX. With a commitment to providing state-of-the-art care and personalized treatment plans, Dr. Burrus helps his patients achieve the best possible outcomes. His use of the latest technologies and techniques ensures that patients receive the highest quality of care in a compassionate and professional environment. For more information on Dr. Burrus's services or to schedule a consultation, please visit his website at or contact his office at (512) 324-9170. Contact Information Dr. M. Tyrrell Burrus, MD Website: Phone: (512) 324-9170 Source: Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
